United Therapeutics (UTHR) Treasury Shares (2009 - 2026)
United Therapeutics (UTHR) posted Treasury Shares of $5.4 billion for Q1 2026, up 27.73% sequentially from $4.3 billion in Q4 2025, and up 56.62% YoY from $3.5 billion in Q1 2025.
United Therapeutics (UTHR) Treasury Shares (2009 - 2026) Analysis & Trends
United Therapeutics has reported Treasury Shares for 18 years, with the latest figure at $5.4 billion in Q1 2026.
- Quarterly Treasury Shares rose 56.62% year-over-year to $5.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 billion (up 56.62% YoY) and the FY2025 annual result came in at $4.3 billion, up 22.62% from the prior year.
- Treasury Shares rose to $5.4 billion in Q1 2026 per UTHR's latest filing, from $4.3 billion in the prior quarter.
- Over five years, Treasury Shares peaked at $35.0 million in Q1 2026 and troughed at $841251.0 in Q4 2022.
- A 5-year average of $25.9 million and a median of $26.6 million in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2026: Treasury Shares changed 0.0% in 2022, then surged 56.62% in 2026.
- Over 5 years, Treasury Shares stood at $2.6 billion in 2022, then changed by 0.0% to $2.6 billion in 2023, then jumped by 34.71% to $3.5 billion in 2024, then grew by 22.62% to $4.3 billion in 2025, then gained by 27.73% to $5.4 billion in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $5.4 billion, $4.3 billion, and $4.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 19.00 Mn |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | 502.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.64 Bn |
| Jun 30, 2026 | 35.35 Mn |
| Jun 30, 2026 | 5.64 Bn |
| Jun 30, 2026 | 35.35 Mn |
| Mar 31, 2026 | 34.97 Mn |
| Mar 31, 2026 | 34.97 Mn |
| Mar 31, 2026 | 5.44 Bn |
| Mar 31, 2026 | 5.44 Bn |
| Dec 31, 2025 | 4.26 Bn |
| Dec 31, 2025 | 4.26 Bn |
| Dec 31, 2025 | 32.81 Mn |
| Dec 31, 2025 | 32.81 Mn |
| Sep 30, 2025 | 32.81 Mn |
| Sep 30, 2025 | 4.26 Bn |
| Sep 30, 2025 | 4.26 Bn |
| Sep 30, 2025 | 32.81 Mn |
| Jun 30, 2025 | 3.47 Bn |
| Jun 30, 2025 | 30.17 Mn |
| Jun 30, 2025 | 30.17 Mn |
| Jun 30, 2025 | 3.47 Bn |